Central Retinal Vein Occlusion With Macular Edema

Also known as: Macular Edema With Central Retinal Vein Occlusions / Central retinal vein occlusion with macular edema (disorder)

DrugDrug NameDrug Description
DB08885AfliberceptA vascular endothelial growth factor (VEGF) inhibitor used to treat Neovascular (Wet) Age-Related Macular Degeneration (AMD), various types of macular edema and diabetic retinopathy, and metastatic colorectal cancer
DrugDrug NamePhaseStatusCount
DB08885Aflibercept1 / 2Completed1
DB01270Ranibizumab3Recruiting1
DB08885Aflibercept4Completed1
DB11077Polyethylene glycol 4004Completed1
DB01839Propylene glycol4Completed1
DB01270Ranibizumab4Unknown Status1
DB08885AfliberceptNot AvailableCompleted1